This is a firm-fixed-price delivery order awarded by the Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, to ICF Incorporated, L.L.C., a global consulting and technology services company. The contract provides continuity of research support services for the Genetic and Rare Diseases (GARD) Information Center and related initiatives from August 1, 2017 to September 29, 2017, with a potential value of $573,856.00. The contract was awarded under the General Services Administration's Professional Services Schedule and did not utilize a set-aside. As a prime contractor, ICF has experience providing a range of professional services to federal agencies, including research and analysis, IT modernization, and public health support.